Fragile X Syndrome
Randi Hagerman
-
I. Description of the problem. Fragile X syndrome (FXS) is the most common inherited form of mental retardation. It causes a spectrum of developmental problems, ranging from learning disabilities and emotional problems (in those with a normal IQ) through all levels of mental retardation. The fragile X premutation can also be associated with developmental problems including attention-deficit/hyperactivity disorder (ADHD) and social deficits in addition to problems with tremor and balance difficulties in aging.
-
A. Epidemiology.
-
Causes intellectual disability in approximately 1 in 2500-4000 in the general population.
-
Responsible for approximately 20%-30% of all cases of X-linked mental retardation.
-
Approximately 1 in 130-259 females and 1 in 250-810 males in the general population carry the premutation (55-200 CGG repeats).
-
No known racial or ethnic differences; identified in all racial groups tested.
-
Both males and females can be unaffected carriers although ADHD, anxiety, and social deficits including autism spectrum disorders (ASDs) can occur in premutation carriers. Approximately 40% of older male carriers and 16% of older female carriers can develop the fragile X-associated tremor ataxia syndrome (FXTAS). Primary ovarian insufficiency (POI) occurs before 40 years of age in about 20% of female carriers.
-
-
B. Genetics. FXS is caused by a mutation in the fragile X mental retardation-1 gene (FMR-1), which is located on the bottom end of the X chromosome. The mutation causes a fragile site or break in the chromosome at that location. The FMR-1 gene was identified and sequenced in 1991. An unusual expansion of a cytosine, guanine, guanine (CGG) nucleotide repetitive sequence was found to be the mutation. Within the FMR-1 gene, normal individuals have a nucleotide CGG sequence that repeats up to 45 times, carriers with a premutation have an expansion of the CGG sequence between 55-200 repeats, and individuals affected with FXS have a CGG repeat number greater than 200 (termed a full mutation). When this occurs, the gene usually becomes methylated or turned off so that little or no FMR-1 protein (FMRP) is made, and the full FXS occurs.A carrier male will pass only X chromosome to all of his daughters, who will be obligate carriers and pass the mutation to 50% of their offspring. A significant expansion of the mutation will often occur in their children so that males and females with intellectual disability are common. A detailed family tree must be drawn to sort out possible carriers and other extended family members who may be affected by FXS or by premutation involvement including FXTAS and POI.
-
-
II. Making the diagnosis. Both behavioral and physical features are included in the fragile X checklist (Fig. 45-1), which serves as a reminder for clinicians of the signs and symptoms of FXS.
-
A. Signs and symptoms in males.
-
1. Early signs and symptoms.
-
Infants with FXS may appear to be normal, although behavior and feeding difficulties have been described including recurrent vomiting.
-
Recurrent otitis media begins in the first year of life for the majority of males affected by this syndrome.
-
Hypotonia is also notable in young boys, with subsequent mild delays in motor milestones.
-
Most boys with FXS and significantly affected girls with fragile X are delayed in the onset of language. Phrases or short sentences are usually delayed until the age of 3 years or older. The language delays in addition to hyperactivity or tantrums are the typical initial concerns leading to medical consultation.
-
Prominent ears with occasional ear cupping, hyperextensible finger joints, double-jointed thumbs, flat feet, and soft skin are seen in the majority of boys with fragile X in early childhood. These physical findings are considered to be part of a connective tissue dysplasia that is related to the absence of FMRP.
-
Young boys with FXS may also have a broad or prominent forehead and a large head circumference.
-
-
2. Later signs and symptoms.
Stay updated, free articles. Join our Telegram channel
-
-

Full access? Get Clinical Tree

